Press and media

4 February 2021
Thursday 4 February 2021 at 13:00 CET About People living with NCDs (PLWNCDs) are at the heart of a deadly burden which causes 82% of premature deaths in low-and middle-income (LMIC) countries. PLWNCDs, their healthcare providers and the communities they serve have a first-hand knowledge on how...
The 148th session of the World Health Organization’s Executive Board (EB) took place on 18-26 January 2021 in Geneva, Switzerland with a focus on the challenges of COVID-19, the need to strengthen health systems. The Governing Board Chair, and Governing Board Secretary were able to attend a variety...
4 February 2021
Join IDF next week on Thursday 4 February 2021, 12:00 p.m. CET for a virtual launch of their new guide for Diabetes Epidemiology Studies. The guide is intended to help researchers conduct proficient and high-quality diabetes epidemiological studies and help inform future diabetes and health service...
We at IAPO are extremely delighted that on Thursday 21st January 2020, the World Health Organization (WHO) Member States and non-state actors expressed their unanimous support to the proposed Global Patient Safety Action Plan 2021-2030 as a key instrument to guide patient safety improvements at all...
The International Alliance of Patients’ Organisations (IAPO) collaborated with BD–Europe to amplify the voices of patients who have been afflicted with healthcare-associated infections (HAIs), sepsis, antimicrobial resistance (AMR) or medication errors. As part of this Voices of Safety campaign,...
4 February 2021
World Cancer Day every 4 February is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education and catalysing personal, collective and government action, we're working together to reimagine a world where millions of...
The 2nd Asia Pacific Patients Congress was held as IAPO’s second fully digital congress on 3-4 December 2020 with over 3000 registered from 66 countries with 298 patient groups, who attended 20 sessions with 66 speakers from 16 countries. Patient groups and thousands of attendees drew together...
Antimicrobial resistance (AMR) is a natural process of pathogens’ adaptation to the drugs we use to kill them, which should normally have a slow evolution-like pace. Our inappropriate use of common antibiotics, antiviral agents and other drugs on all fronts of human and animal health speedwarps...
On Monday 16th November 2020, IAPO board members Karen Alparce-Vilanueva, Dr Neda Milevska-Kostova and Bisi Bright, represented IAPO at the 8th Edition of the Geneva Health Forum where they were part of a multi-stakeholder panel within which a stimulating discussion took place around the topic of...
Since our establishment, IAPO has been dedicated to fighting antimicrobial resistance (AMR) , through development of various policy briefs, analyses, educational materials and advocacy toolkits for its members and patient organisations worldwide in order to turn global best practices into concrete...

Pages

Subscribe to RSS - Press and media